The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients
Open accessAbstract
BACKGROUND: The impact of neuraminidase inhibitor (NAI) treatment on clinical outcomes of public health importance during the 2009-2010 pandemic has not been firmly established. METHODS: We conducted a systematic review and meta-analysis, searching 11 databases (2009 through April 2012) for relevant studies. We used standard methods conforming to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using random effects models. RESULTS: Regarding mortality we observed a nonsignificant reduction associated with NAI treatment (at any time) versus none (OR, 0.72 [95% CI, .51-1.01]). However we observed significant reductions for early treatment (≤48 hours after symptom onset) versus late (OR, 0.38 [95% CI, .27-.53]) and for early treatment versus none (OR, 0.35 [95% CI, .18-.71]). NAI treatment (at any time) versus none was associated with an elevated risk of severe outcome (OR, 1.76 [95% CI, 1.22-2.54]), but early versus late treatment reduced the likelihood (OR, 0.41 [95% CI, .30-.56]). CONCLUSIONS: During the 2009-2010 influenza A(H1N1) pandemic, early initiation of NAI treatment reduced the likelihood of severe outcomes compared with late or no treatment. PROSPERO REGISTRATION: CRD42011001273.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Critically Ill patients with 2009 influenza A(H1N1) in Mexico
Domínguez-Cherit, G. (2009) · JAMA · doi:10.1001/jama.2009.1536 · Cited by 840
Oral oseltamivir treatment of influenza in children
WHITLEY, R. J., HAYDEN, F. G., REISINGER, K. S., YOUNG, N., DUTKOWSKI, R., IPE, D., MILLS, R. G., & WARD, P. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00002 · Cited by 711
Myles, P. R., Semple, M. G., Lim, W. S., Openshaw, P. J. M., Gadd, E. M., Read, R. C., Taylor, B. L., Brett, S. J., McMenamin, J., Enstone, J. E., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200266 · Cited by 82
Self-citation
Research works printed but not linked: 21
- M kel, 2000, The Journal of infection, 40, 42, 10.1053/jinf.1999.0602 · DOI · Paper page
- Nicholson, 2000, Lancet, 355, 1845, 10.1016/S0140-6736(00)02288-1 · DOI · Paper page
- Treanor, 2000, JAMA, 283, 1016, 10.1001/jama.283.8.1016 · DOI · Paper page
- Monto, 1999, Journal of Antimicrobial Chemotherapy, 44, 23, 10.1093/jac/44.suppl_2.23 · DOI
- Kaiser, 2003, Archives of Internal Medicine, 163, 1667, 10.1001/archinte.163.14.1667 · DOI · Paper page
- 2004, CHUNG HUA I HSUEH TSA CHIH, 84, 2132
- 2012, Annals of Internal Medicine, 156, 512, 10.7326/0003-4819-156-7-201204030-00411 · DOI · Paper page
- Donner, 2011, Pharmacoepidemiology and drug safety, 20, 532, 10.1002/pds.2136 · DOI
- Atkins, 2011, Emerging infectious diseases, 17, 1591, 10.3201/eid1709.110295 · DOI
- Grijalva-Otero, 2009, Archives of medical research, 40, 662, 10.1016/j.arcmed.2009.10.010 · DOI
- 2009, DISASTER MED, 3, S109
- Creanga, 2010, Obstetrics & Gynecology, 115, 717, 10.1097/AOG.0b013e3181d57947 · DOI · Paper page
- 2010, New England Journal of Medicine, 362, 27, 10.1056/NEJMoa0910444 · DOI · Paper page
- Siston, 2010, JAMA, 303, 1517, 10.1001/jama.2010.479 · DOI · Paper page
- 2009, BMJ, 339, b5213, 10.1136/bmj.b5213 · DOI · Paper page
- Louie, 2009, JAMA, 302, 1896, 10.1001/jama.2009.1583 · DOI · Paper page
- Lee, 2010, Clinical Infectious Diseases, 50, 1498, 10.1086/652446 · DOI · Paper page
- 2009, New England Journal of Medicine, 361, 2204, 10.1056/NEJMp0910479 · doi:10.1056/nejmp0910479
- Higgins, 2003, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- Egger, 1997, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
- 2003, Journal of Antimicrobial Chemotherapy, 51, 123, 10.1093/jac/dkg007 · DOI · Paper page
Cited by
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy866 · Cited by 795
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
Li, Q., Zhou, L., Zhou, M., Chen, Z., Li, F., Wu, H., Xiang, N., Chen, E., Tang, F., Wang, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304617 · Cited by 688
Muthuri, S. G., Venkatesan, S., Myles, P. R., Leonardi-Bee, J., Al Khuwaitir, T. S. A., Al Mamun, A., Anovadiya, A. P., Azziz-Baumgartner, E., Báez, C., Bassetti, M., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70041-4 · Cited by 644
Self-citationOseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
Dobson, J., Whitley, R. J., Pocock, S., & Monto, A. S. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62449-1 · Cited by 594
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy874 · Cited by 413
Metadata
- Authors
- Muthuri, S. G., Myles, P. R., Venkatesan, S., Leonardi-Bee, J., & Nguyen-Van-Tam, J. S.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-11-29
- Volume
- 207
- Issue
- 4
- Pages
- 553-563
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2165613545
- Cited by
- 195
- References
- 5
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients. https://app.cochat.ai/papers/10.1093/infdis/jis726
- The paper
- Muthuri, S. G., Myles, P. R., Venkatesan, S., Leonardi-Bee, J., & Nguyen-Van-Tam, J. S. (2013). Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jis726
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.